GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma.

Autor: Li Y; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA.; Department of Surgical Oncology and General Surgery, First Hospital of China Medical University, Shenyang, 110001, People's Republic of China., Fan Y; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA.; Department of Surgical Oncology and General Surgery, First Hospital of China Medical University, Shenyang, 110001, People's Republic of China., Xu J; Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, McGovern Medical School, The University of Texas Health Science Center, 1825 Pressler St., Houston, TX, 77030, USA.; Fujian Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, 350001, People's Republic of China., Huo L; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA., Scott AW; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA., Jin J; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA., Yang B; Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, McGovern Medical School, The University of Texas Health Science Center, 1825 Pressler St., Houston, TX, 77030, USA., Shao S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA., Ma L; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA., Wang Y; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA., Yao X; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA., Pool Pizzi M; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA., Sewastjanow Da Silva M; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA., Zhang G; Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, McGovern Medical School, The University of Texas Health Science Center, 1825 Pressler St., Houston, TX, 77030, USA., Zhuo L; Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, McGovern Medical School, The University of Texas Health Science Center, 1825 Pressler St., Houston, TX, 77030, USA., Cho EJ; Division of Chemical Biology and Medicinal Chemistry, College of Pharmacy, The University of Texas at Austin, Austin, TX, 78712, USA., Dalby KN; Division of Chemical Biology and Medicinal Chemistry, College of Pharmacy, The University of Texas at Austin, Austin, TX, 78712, USA., Shanbhag ND; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA., Wang Z; Department of Surgical Oncology and General Surgery, First Hospital of China Medical University, Shenyang, 110001, People's Republic of China. josieon826@sina.cn., Li W; Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, McGovern Medical School, The University of Texas Health Science Center, 1825 Pressler St., Houston, TX, 77030, USA. wenliang.li@uth.tmc.edu., Song S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA. ssong@mdanderson.org., Ajani JA; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA. jajani@mdanderson.org.

Publikováno v: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2022 Aug 23; Vol. 41 (1), pp. 257. Date of Electronic Publication: 2022 Aug 23.

Identification of circulating tumor cells using 4-color fluorescence in situ hybridization: Validation of a noninvasive aid for ruling out lung cancer in patients with low-dose computed tomography-detected lung nodules.

Autor: Katz RL; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zaidi TM; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Pujara D; Department of Neurology, McGovern Medical School at The University of Texas Health Science Center at Houston, Houston, Texas., Shanbhag ND; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Truong D; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Patil S; Department of Internal Medicine, McGovern Medical School at The University of Texas Health Science Center at Houston, Houston, Texas., Mehran RJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas., El-Zein RA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Radiology, Houston Methodist Research Institute, Houston, Texas., Shete SS; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kuban JD; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Publikováno v: Cancer cytopathology [Cancer Cytopathol] 2020 Aug; Vol. 128 (8), pp. 553-562. Date of Electronic Publication: 2020 Apr 22.

Cancer stem cells in esophageal cancer and response to therapy.

Autor: Harada K; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Pool Pizzi M; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Baba H; Department of Gastroenterological Surgery, Graduate School of Medical Science, Kumamoto University, Honjo, Japan., Shanbhag ND; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Song S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ajani JA; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Publikováno v: Cancer [Cancer] 2018 Oct 15; Vol. 124 (20), pp. 3962-3964. Date of Electronic Publication: 2018 Oct 25.